• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Global Continuous Glucose Monitoring (CGM) Market Forecast including Production,
Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/continuous-glucose-monitoring-market-57
According to the International Diabetes Federation (IDF), around 75% of the diabetic population
lives in low and middle income countries such as Mexico, India, China, Brazil, Colombia,
Libya, Iran, and Turkey. Asia-Pacific accounted for over 50% of the global diabetic population
in 2015, with prevalence rate being the highest in China and India. Market penetration in these
countries is relatively low, mainly due to high prices of CGM devices. However, the scenario in
Asia Pacific region is expected to change in the near future due to increasing patient awareness
and decreasing prices of these systems., which would change the industry dynamics and impact
the market growth positively, expanding at a CAGR of 15% during the forecast period.
Global players need to explore the untapped geographies and simultaneously should focus on
upgrading their CGM technology
Competitor Analysis:
Major players in the global continuous glucose monitoring market include,
Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Bayer AG, Medtronic, Inc., Animas
Corporation, Nova Biomedical Corporation, Ypsomed AG, GlySens Incorporated, Insulet
Corporation, and Sensionics Incorporated.